Stephen Harrison, MD, on the REGENERATE Clinical Trial of Obeticholic Acid for NASH

In this podcast, Stephen Harrison, MD, highlights the importance of new treatment options for patients with nonalcoholic steatohepatitis, findings from the REGENERATE clinical trial that were presented at the American College of Gastroenterology (ACG) 2019 Annual Scientific Meeting and Postgraduate Course, and more.

Stephen Harrison, MD, is medical director of Pinnacle Clinical Research in San Antonio, Texas, and a visiting professor of hepatology at the University of Oxford in Oxford, England. 



Harrison S. Positive results from REGENERATE: a phase 3 international, randomized, placebo-controlled study evaluating obeticholic acid treatment for NASH [abstract 11]. Presented at: ACG 2019 Annual Scientific Meeting and Postgraduate Course; October 25-30, 2019; San Antonio, TX.


Submit Feedback